[go: up one dir, main page]

EE200200012A - Suukaudselt manustatav maskeeritud maitsega vedelpreparaat - Google Patents

Suukaudselt manustatav maskeeritud maitsega vedelpreparaat

Info

Publication number
EE200200012A
EE200200012A EEP200200012A EEP200200012A EE200200012A EE 200200012 A EE200200012 A EE 200200012A EE P200200012 A EEP200200012 A EE P200200012A EE P200200012 A EEP200200012 A EE P200200012A EE 200200012 A EE200200012 A EE 200200012A
Authority
EE
Estonia
Prior art keywords
oral liquid
liquid preparation
masked taste
masked
taste
Prior art date
Application number
EEP200200012A
Other languages
English (en)
Inventor
Yu Danny
Roche Edward
Original Assignee
Ortho-Mcneil Pharmaceutical, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho-Mcneil Pharmaceutical, Inc. filed Critical Ortho-Mcneil Pharmaceutical, Inc.
Publication of EE200200012A publication Critical patent/EE200200012A/et
Publication of EE05147B1 publication Critical patent/EE05147B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP200200012A 1999-07-09 2000-06-21 Suukaudselt manustatav maskeeritud maitsega vedel preparaat EE05147B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14301999P 1999-07-09 1999-07-09
PCT/US2000/016969 WO2001003698A1 (en) 1999-07-09 2000-06-21 Taste masked pharmaceutical liquid formulations

Publications (2)

Publication Number Publication Date
EE200200012A true EE200200012A (et) 2003-02-17
EE05147B1 EE05147B1 (et) 2009-04-15

Family

ID=22502238

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200012A EE05147B1 (et) 1999-07-09 2000-06-21 Suukaudselt manustatav maskeeritud maitsega vedel preparaat

Country Status (25)

Country Link
US (2) US6482823B1 (et)
EP (1) EP1194153B1 (et)
JP (1) JP2003504335A (et)
KR (2) KR100675809B1 (et)
CN (1) CN1174740C (et)
AR (1) AR027179A1 (et)
AT (1) ATE265852T1 (et)
AU (1) AU773555B2 (et)
BR (1) BR0012326A (et)
CA (1) CA2377916C (et)
DE (1) DE60010464T2 (et)
DK (1) DK1194153T3 (et)
EE (1) EE05147B1 (et)
ES (1) ES2219360T3 (et)
HR (1) HRP20020119A2 (et)
HU (1) HUP0201765A3 (et)
IL (2) IL147510A0 (et)
MX (1) MXPA02000331A (et)
NO (1) NO20020086L (et)
NZ (1) NZ516486A (et)
PL (1) PL197812B1 (et)
PT (1) PT1194153E (et)
SK (1) SK322002A3 (et)
TR (1) TR200200710T2 (et)
WO (1) WO2001003698A1 (et)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1276470E (pt) * 2000-04-20 2007-08-13 Novartis Ag Composição de revestimento para dissimular o sabor
WO2002072102A1 (en) * 2001-03-05 2002-09-19 Ortho-Mcneil Pharmaceutical, Inc. Taste masked liquid pharmaceutical compositions
US20040013737A1 (en) * 2002-07-19 2004-01-22 Philippe Becourt Taste masked oral composition of telithromycin
AU2003257093A1 (en) * 2002-08-02 2004-02-23 Eggs In The Pipeline, Llc. System for adding consumable enhancing additives to drinking water
US20080020096A1 (en) * 2003-08-01 2008-01-24 Blum Bradley J System for Adding Consumable Enhancing Additives to Drinking Water
DK1669090T3 (en) * 2003-09-12 2016-06-06 Ryukakusan Co Ltd Bitterness masking particulate gel
US7713482B2 (en) 2003-12-18 2010-05-11 The Clorox Company Control scheme for enhanced filtered water systems
US7378015B2 (en) * 2003-12-18 2008-05-27 The Clorox Company Filtered water enhancements
JP2007532623A (ja) 2004-04-12 2007-11-15 ファイザー・プロダクツ・インク 破裂型多重粒子中の味マスキング薬物
JP2006232789A (ja) * 2005-02-28 2006-09-07 Sawai Pharmaceutical Co Ltd 経口製剤用組成物及びその製造方法
US20060216355A1 (en) * 2005-03-28 2006-09-28 Donald Spector Encapsulated pharmaceuticals in a medium having non-encapsulated flavoring agents
US7874489B2 (en) * 2005-06-20 2011-01-25 Authentiform Technologies, Llc Product authentication
US8247018B2 (en) * 2005-06-20 2012-08-21 Authentiform Technologies, Llc Methods for quality control
EP1907988B1 (en) * 2005-06-20 2013-11-06 AuthentiForm Technologies, L.L.C. Systems and methods for product authentication
US7973022B2 (en) * 2006-02-17 2011-07-05 Idexx Laboratories, Inc. Fluoroquinolone carboxylic acid salt compositions
US20070197469A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V Fluoroquinolone carboxylic acid salt compositions
EP2091519B1 (en) 2006-11-30 2015-06-24 Bend Research, Inc Multiparticulates of spray-coated drug and polymer on a meltable core
ES2552723T3 (es) * 2008-05-06 2015-12-01 Dexcel Pharma Technologies Ltd. Formulación de bencimidazol estable
CN101618217B (zh) * 2009-07-27 2011-12-28 洛阳君山制药有限公司 一种安胃片的包衣方法
KR101636958B1 (ko) * 2009-09-11 2016-07-06 주식회사 대웅제약 우루소데옥시콜린산-합성하이드로탈사이트-유드라짓 혼성체, 이를 함유하는 약학 조성물 및 그 제조방법
EP2509631A4 (en) * 2009-12-10 2014-04-02 Monosol Rx Llc PH-SENSITIVE COMPOUNDS FOR MASKING THE TASTE OF ORAL STRIPS IN THE FORM OF THIN FILM
JP2013515004A (ja) 2009-12-18 2013-05-02 エクソドス ライフ サイエンシーズ リミテッド パートナーシップ 安定な液体薬剤のための方法および組成物
EP2915098A4 (en) 2012-10-30 2016-07-06 Certirx Corp PRODUCT, IMAGE, OR DOCUMENT AUTHENTICATION AND VERIFICATION AND OBJECT IDENTIFICATION
EP2968181B1 (en) 2013-03-15 2019-10-16 Aprecia Pharmaceuticals LLC Rapidly dispersible dosage form of topiramate
WO2014143935A1 (en) 2013-03-15 2014-09-18 Aprecia Pharmaceuticals Company Rapidly dispersible dosage form of oxcarbazepine
KR102414503B1 (ko) 2016-03-17 2022-06-29 티오제네시스 테라퓨틱스, 인크. 시스테아민의 조절 방출을 위한 조성물 및 시스테아민 민감성 장애의 전신 치료
KR102088315B1 (ko) 2017-10-23 2020-03-13 주식회사 웅진릴리에뜨 장용성 캡슐의 이취 마스킹 방법 및 이를 이용한 이취의 마스킹 처리가 이루어진 장용성 캡슐
WO2019142063A1 (en) * 2018-01-22 2019-07-25 Johnson & Johnson Consumer Inc. Perforated capsules
WO2020104837A1 (en) 2018-11-21 2020-05-28 Rosemont Pharmaceuticals Limited Oral topiramate suspension formulations with extended shelf stability and enhanced bioavailability
CN117503701A (zh) * 2023-12-08 2024-02-06 斯坦德医药研发(江苏)有限公司 左氧氟沙星口服混悬液制剂及制剂制造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62226926A (ja) 1986-03-27 1987-10-05 Teisan Seiyaku Kk 持続性複合顆粒剤
US5065094A (en) 1990-08-07 1991-11-12 Seagate Technology, Inc. Two terminal magnetoresistive sensor having DC blocking capacitor
FR2665635A1 (fr) * 1990-08-10 1992-02-14 Merck Sharp & Dohme Composition pharmaceutique fluide a base d'un complexe metallique et son procede de preparation.
CA2068402C (en) * 1991-06-14 1998-09-22 Michael R. Hoy Taste mask coatings for preparation of chewable pharmaceutical tablets
US5599556A (en) 1991-12-31 1997-02-04 Abbott Laboratories Prolamine coatings for taste masking
DE4200821A1 (de) 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
FR2694751B1 (fr) 1992-08-14 1994-11-25 Bouchara Sa Nouveaux dérivés sulfonamides, leurs procédés de préparation et les compositions en renfermant.
US5614222A (en) * 1994-10-25 1997-03-25 Kaplan; Milton R. Stable aqueous drug suspensions and methods for preparation thereof

Also Published As

Publication number Publication date
EP1194153B1 (en) 2004-05-06
AR027179A1 (es) 2003-03-19
IL147510A0 (en) 2002-08-14
PL197812B1 (pl) 2008-04-30
CN1360504A (zh) 2002-07-24
NO20020086L (no) 2002-03-05
MXPA02000331A (es) 2002-06-21
WO2001003698A1 (en) 2001-01-18
HRP20020119A2 (en) 2003-12-31
EP1194153A1 (en) 2002-04-10
BR0012326A (pt) 2002-03-12
AU773555B2 (en) 2004-05-27
ATE265852T1 (de) 2004-05-15
HUP0201765A2 (hu) 2002-11-28
CA2377916C (en) 2008-03-11
TR200200710T2 (tr) 2002-08-21
DE60010464T2 (de) 2005-05-12
US6482823B1 (en) 2002-11-19
NO20020086D0 (no) 2002-01-08
KR100675809B1 (ko) 2007-02-01
HUP0201765A3 (en) 2004-05-28
EE05147B1 (et) 2009-04-15
CN1174740C (zh) 2004-11-10
DK1194153T3 (da) 2004-08-02
KR20020031382A (ko) 2002-05-01
US6586012B2 (en) 2003-07-01
AU5880200A (en) 2001-01-30
US20030064107A1 (en) 2003-04-03
DE60010464D1 (de) 2004-06-09
CA2377916A1 (en) 2001-01-18
JP2003504335A (ja) 2003-02-04
ES2219360T3 (es) 2004-12-01
IL147510A (en) 2007-06-03
PT1194153E (pt) 2004-09-30
NZ516486A (en) 2003-10-31
KR20020029668A (ko) 2002-04-19
SK322002A3 (en) 2003-02-04
PL352761A1 (en) 2003-09-08

Similar Documents

Publication Publication Date Title
EE200200012A (et) Suukaudselt manustatav maskeeritud maitsega vedelpreparaat
ATE411068T1 (de) Medikamentspender
DE59912838D1 (de) Pharmazeutisches faktor vii-präparat
DE60009395D1 (de) Bildanzeige
DE69908021D1 (de) Ziprasidonhaltige Arzneimittel
ATE311915T1 (de) Medikamentenspender
DK1466615T3 (da) Farmaceutisk præparat
EE200200150A (et) Preparaat
IS6210A (is) Matvöruhylki
FR2800357B1 (fr) Verseur ameliore et capsule a verseur incorpore
NO20022606L (no) Farmasöytiske kombinasjoner
DE60014289D1 (de) Kaffeebrühgerät
DK1168920T3 (da) (S)-enantiomerberiget fipronilpræparat
ID30397A (id) Larutan oral prukaloprida
DE10085211T1 (de) Schokoladenprodukt mit Wegbrechstück
DE60023341D1 (de) Orale lösung enthaltend galanthamine und ein süssungsmittel
EE200100697A (et) Farmatseutiline kompleks
DE60008237D1 (de) Lamivudin enthaltende arzneimittel
NO20014853D0 (no) Smakstilsetning
ATA5099A (de) Stranggiesskokille
EP1336408A4 (en) WATER-SOLVENT LIQUID MEDICAMENT FOR INHALATION
SE9800251D0 (sv) A novel pharmaceutical preparation
ATE310809T1 (de) Pharmazeutisches faktor vii-präparat
FIU990361U0 (fi) Hammaslankatuote
DE69912111D1 (de) Burstformung

Legal Events

Date Code Title Description
MM4A Lapsed by not paying the annual fees

Effective date: 20090621